Retrospective observational study assessed antimicrobial resistance in Acinetobacter and Pseudomonas, indicating significant trends for infection control.
Key Points
Acinetobacter baumannii and Pseudomonas aeruginosa showed the highest resistance levels, indicating urgent need for effective treatment plans.
Median MARI values for the leading resistant pathogens exceeded 0.25 in 2024, particularly affecting intensive care units.
Multiple Antibiotic Resistance Index evaluations reveal significant interspecies differences, highlighting targeted treatment strategies are essential.
Ongoing local surveillance is crucial for refining empirical treatment protocols and enhancing antimicrobial stewardship initiatives.